001 Expedited Drug Development - James Mencel
CMC Live - Chemistry, Manufacturing & Controls
English - July 31, 2020 11:53 - 18 minutes - 17.3 MBChemistry Science Education How To controls manufacturing chemistry Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
What We Covered00:23 – James discusses regulations and the importance of starting with big ideas when it comes to expedited drug development programs05:44 – Breakthrough designations that occur as a result of expedited drug development programs08:20 – When a sponsor should consider applying for expedited drug development11:14 – James speaks to his unique background and experiences with CMC including obstacles and challenges that CMC faces15:02 – What companies can do to get ahead of the curve when it comes to drug development18:10 – Ed and Miranda thank James for joining the showTweetable Quotes
“When you are in a program that gets expedited, the attention is for the program to move quickly. And there are several ways in which it can move quickly. But almost all of them lead to a very shortened timeframe for CMC. So what it gets you is the FDA’s aware that there is stress on CMC.”
“If you know you’ve got a receptor site – a validated model – some sponsors know from the outset they’re going to approach the FDA even before they go into Phase One because they have a receptor site model. And if they get a model that hits then they’re going to request some sort of expedited status.”
“The first question to ask yourself is, ‘Can this process do the job?’ Because, if this program goes expedited, this process that I’m running right now may be the commercial process whether I like it or not.”
Relevant LinksLeadership - https://dsinpharmatics.com/leadership/#leadership
Project Management - https://dsinpharmatics.com/leadership#projectmanagement
Analytical - https://dsinpharmatics.com/leadership#analytical
Drug Substance - https://dsinpharmatics.com/leadership#drugsubstance
Drug Product - https://dsinpharmatics.com/leadership#drugproduct
Regulatory - https://dsinpharmatics.com/leadership#regulatory
Quality Assurance - https://dsinpharmatics.com/leadership#qualityassurance
Biologics & Microbiology - https://dsinpharmatics.com/leadership#biologics
Formulation & Clinical Ops - https://dsinpharmatics.com/leadership#formulation
Design Space InPharmatics - LinkedIn